Skip to main content
. 2014 Apr 17;9(5):951–959. doi: 10.2215/CJN.08310813

Table 2.

Independent association of BMI with individual steps in deceased donor transplant process

Step in Deceased Donor Transplant Process Men Women
Hazard Ratio 
(95% Confidence Interval) Hazard Ratio 
(95% Confidence Interval)
Activation to the waiting list
 Patients (n) 395,812 306,644
 BMI (kg/m2)
  <18.5 0.92 (0.88 to 0.96) 0.90 (0.87 to 0.93)
  18.5–24.9 1.00 1.00
  25.0–29.9 1.26 (1.23 to 1.29) 1.07 (1.04 to 1.10)
  30.0–34.9 1.36 (1.32 to 1.39) 1.10 (1.06 to 1.13)
  35.0–39.9 1.12 (1.08 to 1.17) 0.84 (0.81 to 0.88)
  ≥40.0 0.74 (0.71 to 0.78) 0.50 (0.48 to 0.53)
Transplantation from a deceased donor after wait-listing
 Patients (n) 84,939 57,662
 BMI (kg/m2)
  <18.5 1.04 (0.99 to 1.10) 0.98 (0.92 to 1.04)
  18.5–24.9 1.00 1.00
  25.0–29.9 1.00 (0.97 to 1.03) 0.92 (0.88 to 0.96)
  30.0–34.9 0.99 (0.95 to 1.03) 0.87 (0.83 to 0.92)
  35.0–39.9 0.88 (0.83 to 0.93) 0.77 (0.72 to 0.82)
  ≥40.0 0.72 (0.66 to 0.78) 0.65 (0.59 to 0.71)

Separate multivariate Cox regression models were performed in men and women for the outcome of activation to the waiting list, and transplantation from a deceased donor after wait-listing. All models included adjustment for the following factors: age, race, cause of ESRD, history of comorbid conditions (ischemic heart disease, cerebrovascular accident, congestive heart failure, peripheral vascular disease, cancer), functional status, year of first ESRD treatment, type of medical insurance, and RUCA codes. The Cox models for the outcome of deceased donor transplantation after wait-listing also included adjustment for ABO blood group and panel reactive antibodies.